Prognostic Impact of Hyperpolypharmacy Due to Noncardiovascular Medications in Patients After Acute Decompensated Heart Failure ― Insights From the Clue of Risk Stratification in the Elderly Patients…

Overview of attention for article published in Circulation Journal, August 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 45,401 followers.

RT @JCIRC_IPR: In patients after acute decompensated heart failure, hyperpolypharmacy was common and significantly associated with an incre…

In patients after acute decompensated heart failure, hyperpolypharmacy was common and significantly associated with an increased risk of all-cause death. By Masafumi Kanai https://t.co/UvCIFS8b9b #circ_j #CardioTwitter https://t.co/snei4FLyHN

RT @JCIRC_IPR: In patients after acute decompensated heart failure, hyperpolypharmacy was common and significantly associated with an incre…

RT @JCIRC_IPR: In patients after acute decompensated heart failure, hyperpolypharmacy was common and significantly associated with an incre…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.